<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Causes of postoperative ocular complaints</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Causes of postoperative ocular complaints</h1>
<div class="graphic"><div class="figure"><div class="ttl">Causes of postoperative ocular complaints</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Associated factors<br/> (not necessarily causal)</td> <td class="subtitle1">Clinical presentation</td> <td class="subtitle1">Duration of POVL</td> <td class="subtitle1">Workup</td> <td class="subtitle1">Treatment</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Visual loss with pain</td> </tr> <tr> <td class="indent1">Corneal <span class="nowrap_whitespace">abrasion<sup>[1-5]</sup></span></td> <td> <ul> <li>Any type of surgery</li> <li>Prolonged surgery</li> <li>Exposure of cornea</li> <li>Trauma</li> <li>Surgery in non-supine position</li> <li>Increased age</li> </ul> </td> <td> <ul> <li>Onset immediate after emergence from anesthesia</li> <li>Usually unilateral</li> <li>Painful</li> <li>Foreign body sensation</li> <li>Conjunctival erythema, tearing, photophobia</li> <li>Normal pupillary reflexes</li> <li>Blurred vision to no visual deficit</li> </ul> </td> <td> <ul> <li>24 to 48 hours</li> </ul> </td> <td> <ul> <li>History</li> <li>Symptoms</li> <li>External eye exam</li> <li>Pupillary light reflexes</li> <li>Fluorescein stain and slit lamp exam</li> <li>Topical proparacaine*</li> </ul> </td> <td> <ul> <li>Prophylactic antibiotic and lubricant eye drops</li> </ul> </td> </tr> <tr> <td class="indent1">Acute angle closure <span class="nowrap_whitespace">glaucoma<sup>[6-9]</sup></span></td> <td> <ul> <li>Any type of surgery</li> <li>General anesthesia</li> <li>Drugs: adrenergic, anticholinergic, antihistamines, antiparkinsonian, mydriatic, cholinergic, antidepressants</li> <li>Genetic/anatomic predisposition</li> <li>Female</li> <li>Hypermetropia</li> </ul> </td> <td> <ul> <li>Onset may be delayed &gt;12 hours postop</li> <li>Unilateral &gt; bilateral</li> <li>Pain: boring quality with ipsilateral headache</li> <li>Intermittent blurring of vision with halos</li> <li>Nausea, vomiting</li> <li>Mid-dilated nonreactive pupil</li> <li>Conjunctival erythema</li> <li>Corneal epithelial edema</li> <li>IOP &gt;21 mmHg</li> </ul> </td> <td> <ul> <li>Until IOP controlled</li> <li><strong>Treatment required within a few hours of onset to prevent permanent vision loss</strong></li> </ul> </td> <td> <ul> <li>History</li> <li>Symptoms</li> <li>External eye exam</li> <li>IOP &gt;21 mmHg</li> <li>Avoid dilated funduscopic exam as it may worsen symptoms</li> </ul> </td> <td> <ul> <li>Topical and systemic medication to reduce IOP</li> <li>Iridotomy for refractory <span class="arrow">↑</span> IOP</li> <li>Temporizing maneuvers (ie, anterior chamber paracentesis)</li> <li>Avoid eye patch or other Rx that dilates pupils</li> </ul> </td> </tr> <tr> <td class="indent1">Retrobulbar <span class="nowrap_whitespace">hematoma<sup>[10-14]</sup></span></td> <td> <ul> <li>Orbital trauma</li> <li>Head and neck procedures</li> <li>May occur (rarely) with other surgical procedures when other associated risk factors are present: orbital floor fracture and s/p repair, anticoagulation, uncontrolled hypertension, straining or Valsalva, sneezing, vomiting</li> </ul> </td> <td> <ul> <li>Most vision loss within 3 to 24 hours, but may be delayed up to seven to nine days</li> <li>Unilateral</li> <li>Severe, stabbing pain; pressure</li> <li>Visual loss from hematoma causing optic nerve ischemia, direct compression, or central retinal artery occlusion</li> <li>Nausea, vomiting</li> <li>Diplopia, ophthalmoplegia</li> <li>Visual flashes</li> <li>Relative afferent pupillary defect or absent pupillary reflex</li> <li>Eyelid hematoma/ecchymosis</li> <li>Subconjunctival hemorrhage</li> <li>Proptosis</li> </ul> </td> <td> <ul> <li>Depends on time to effective treatment</li> <li><strong>Treatment required within a few hours of onset to prevent permanent vision loss</strong></li> </ul> </td> <td> <ul> <li>History</li> <li>External eye exam with pupillary light reflexes</li> <li>Imaging if necessary, but may delay Rx</li> </ul> </td> <td> <ul> <li>Surgical emergency if visual loss present</li> <li>Lateral canthotomy or inferior cantholysis</li> <li>May give topical medications to lower IOP if surgery delayed</li> </ul> </td> </tr> <tr> <td class="indent1">Pituitary <span class="nowrap_whitespace">apoplexy<sup>[15-17]</sup></span></td> <td> <ul> <li>Cardiac surgery; one case report after transurethral prostate surgery</li> <li>Reduced blood flow to pituitary: severe hemorrhagic hypotension, head trauma, pituitary irradiation</li> <li>Sudden increase in blood flow to the pituitary</li> <li>Stimulation of the pituitary</li> <li>Anticoagulation</li> </ul> </td> <td> <ul> <li>Onset immediate to delayed by three months</li> <li>Severe headache</li> <li>Blurred vision to visual field defect to blindness</li> <li>Cranial nerve III commonly involved with dilated, nonreactive pupil</li> <li>Ophthalmoplegia</li> <li>Altered mental status</li> <li>Possible Addisonian crisis</li> </ul> </td> <td> <ul> <li>Full recovery to permanent blindness (especially for chiasmal injuries)</li> </ul> </td> <td> <ul> <li>CT/MRI imaging of head</li> <li>Lab: electrolytes, glucose, pituitary hormones</li> </ul> </td> <td> <ul> <li>Surgical decompression for visual changes or altered mental status</li> <li>Endocrine replacement as necessary including high-dose corticosteroids</li> </ul> </td> </tr> <tr> <td class="indent1">Posterior reversible <span class="nowrap_whitespace">encephalopathy<sup>[18-22]</sup></span></td> <td> <ul> <li>Preeclampsia, eclampsia</li> <li>Not commonly associated with surgery</li> <li>Immunosuppressants</li> <li>Chemotherapy</li> <li>Infection</li> <li>Vascular disease</li> <li>Renal disease</li> </ul> </td> <td> <ul> <li>Three postoperative cases: onset immediate after emergence from anesthesia</li> <li>May have diffuse headache</li> <li>Blurred vision, homonymous hemianopia, blindness</li> <li>Nausea, vomiting</li> <li>Seizures</li> <li>Brainstem symptoms</li> <li>Hemiplegia</li> <li>Altered mental status</li> <li>Normal pupillary light reflexes</li> <li>Normal funduscopic exam</li> <li>Brisk DTRs</li> <li>Positive Babinski</li> </ul> </td> <td> <ul> <li>Average seven days; range from one day to permanent if progresses to infarction</li> </ul> </td> <td> <ul> <li>DWI MRI brain showing vasogenic edema posterior circulation, especially subcortical white matter</li> </ul> </td> <td> <ul> <li>Antihypertensives</li> <li>Antiseizure medications for seizures</li> <li>Mannitol for cerebral edema</li> <li>Magnesium sulfate for preeclampsia/eclampsia</li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="6">Visual loss without pain</td> </tr> <tr> <td class="indent1">Anterior ischemic optic <span class="nowrap_whitespace">neuropathy<sup>[23-28]</sup></span></td> <td> <ul> <li>Cardiac surgery</li> <li>Prone spine surgery</li> <li>Head and neck surgery</li> <li>Older age</li> <li>Vascular risk factors</li> <li>Anemia</li> <li>Vasopressor use</li> <li>Hypotension</li> <li>Small optic nerve cup-to-disc ratio</li> <li>Aberrant physiology or anatomy in the setting of reduced perfusion pressure</li> </ul> </td> <td> <ul> <li>Onset immediate; may be delayed to POD one to three</li> <li>Bilateral &gt; unilateral</li> <li>Progresses for a few days before stabilizing</li> <li>Altitudinal field cuts, scotoma to complete loss of vision with no light perception</li> <li>Relative afferent pupillary defect if asymmetric or amaurotic pupils</li> <li>Funduscopic examination: optic disc swelling, attenuated vessels, splinter hemorrhages</li> </ul> </td> <td> <ul> <li>Usually permanent; may have small degree of recovery</li> </ul> </td> <td> <ul> <li>History</li> <li>Symptoms</li> <li>Pupillary light reflexes</li> <li>External eye exam</li> <li>Dilated funduscopic exam</li> </ul> </td> <td> <ul> <li>None proven</li> <li>Theoretical: optimized hemodynamics, glucocorticoids, mannitol, hyperbaric O<sub>2</sub></li> </ul> </td> </tr> <tr> <td class="indent1">Posterior ischemic optic <span class="nowrap_whitespace">neuropathy<sup>[23-29]</sup></span></td> <td> <ul> <li>Prone spinal procedures</li> <li>Bilateral head and neck procedures</li> <li>Cardiac surgery</li> <li>Prolonged duration in position with increased venous pressure in head: prone, Trendelenburg, Wilson frame</li> <li>Large blood loss</li> <li>Large fluid resuscitation, high crystalloid/colloid ratio</li> <li>Wilson frame</li> <li>Male sex</li> <li>Obesity in prone position</li> </ul> </td> <td> <ul> <li>Onset usually immediate after emergence from anesthesia, no progression</li> <li>Bilateral &gt;&gt; unilateral</li> <li>Altitudinal field cuts, scotoma to complete loss of vision with no light perception</li> <li>Relative afferent pupillary defect if asymmetric or amaurotic pupils</li> <li>Funduscopic exam normal</li> </ul> </td> <td> <ul> <li>Usually permanent; may have small degree of recovery</li> </ul> </td> <td> <ul> <li>History</li> <li>Symptoms</li> <li>Pupillary light reflexes</li> <li>External eye exam</li> <li>Dilated funduscopic exam</li> </ul> </td> <td> <ul> <li>None proven</li> <li>Theoretical: optimized hemodynamics, glucocorticoids, mannitol, hyperbaric O<sub>2</sub></li> </ul> </td> </tr> <tr> <td class="indent1">Cerebral or cortical visual <span class="nowrap_whitespace">loss<sup>[23,24,27,28]</sup></span></td> <td> <ul> <li>Spine fusion</li> <li>Cardiac surgery</li> <li>Nonfusion orthopedic surgery</li> <li>&lt;18 years old</li> <li>Charlson risk index &gt;0</li> <li>Infarction due to emboli or hypotension</li> </ul> </td> <td> <ul> <li>Onset immediate after emergence from anesthesia</li> <li>Bilateral: total blindness or small area preserved central vision</li> <li>Unilateral: contralateral homonymous hemianopia</li> <li>Pupillary light reflexes normal</li> <li>Funduscopic exam normal</li> </ul> </td> <td> <ul> <li>Some recovery possible; rarely complete</li> <li><strong>Treatment required within a few hours of onset to prevent permanent vision loss</strong></li> </ul> </td> <td> <ul> <li>CT or MRI</li> </ul> </td> <td> <ul> <li>Acute stroke reperfusion therapy. Thrombolysis may be contraindicated in postoperative patients. Mechanical thrombectomy may be possible in some patients.</li> <li>Normalization of blood pressure, cardiac output, oxygenation</li> </ul> </td> </tr> <tr> <td class="indent1">Central retinal artery <span class="nowrap_whitespace">occlusion<sup>[23-25,27,30,31]</sup></span></td> <td> <ul> <li>Prone procedures, especially spine</li> <li>Cardiac surgery</li> <li>Head and neck surgery</li> <li>Emboli</li> <li>Horseshoe headrest</li> <li>Intraocular gas bubbles within two months of GA with nitrous oxide</li> </ul> </td> <td> <ul> <li>Onset immediate after emergence from anesthesia</li> <li>Unilateral</li> <li>Complete or nearly complete loss of vision in the affected eye</li> <li>Pupillary light reflex sluggish to absent; relative afferent pupillary if caused by globe compression; may have signs of periorbital trauma</li> <li>Retinal whitening on funduscopic exam</li> </ul> </td> <td> <ul> <li>Usually permanent, severe visual loss in affected eye</li> <li><strong>If treatment is attempted, it must be performed within a few hours of onset to prevent permanent vision loss</strong></li> </ul> </td> <td> <ul> <li>External eye exam</li> <li>IOP measurement</li> <li>Pupillary light reflexes</li> <li>Funduscopic exam</li> </ul> </td> <td> <ul> <li>None proven</li> <li>Theoretical: inhaled O<sub>2</sub> with 5% CO<sub>2</sub>, acetazolamide</li> <li>Controversial, especially in postoperative setting: thrombolysis</li> </ul> </td> </tr> <tr> <td class="indent1">Glycine-induced visual <span class="nowrap_whitespace">loss<sup>[32-37]</sup></span></td> <td> <ul> <li>Transurethral prostate surgery</li> <li>Hysteroscopy</li> <li>Long operative time</li> <li>Large irrigant absorption</li> <li>Increased height of irrigation bag</li> <li>High-pressure irrigation</li> <li>Head-down position</li> </ul> </td> <td> <ul> <li>Onset intraoperative if awake; up to several hours postoperatively</li> <li>Blurred vision</li> <li>Sluggish to fixed and dilated pupils</li> <li>Funduscopic exam normal</li> </ul> </td> <td> <ul> <li>&lt;24 hours; may be longer if severe hyponatremia and other neurological/cardiac dysfunction</li> </ul> </td> <td> <ul> <li>History</li> <li>Lab: serum glycine and ammonia levels</li> </ul> </td> <td> <ul> <li>Correct volume overload and electrolyte abnormalities</li> <li>Supportive</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>IOP: intraocular pressure; Rx: treatment; CT: computerized tomography; MRI: magnetic resonance imaging; DWI: diffused weighted imaging; GA: general anesthesia.</p>
* For patients with suspected corneal abrasion and eye pain/discomfort, topical proparacaine may be used to make a presumptive diagnosis. After examining the eye to ensure the absence of a foreign body and confirming normal pupil reactivity, one drop of ophthalmic proparacaine 0.5% is instilled into the affected eye. Immediate relief of pain is consistent with the diagnosis of corneal abrasion, though relief will also occur if pain is caused by dry cornea or a small undetected foreign body. Ophthalmology should be consulted urgently for abnormal pupil reactivity, or if pain is not relieved within one minute after administration of proparacaine<sup>[5]</sup>.</div><div class="graphic_reference">References:
<ol>
<li>Roth S, Thisted RA, Erickson JP, et al. Eye injuries after nonocular surgery. A study of 60,965 anesthetics from 1988 to 1992. Anesthesiology 1996; 85:1020.</li>
<li>Vetter TR, Ali NM, Boudreaux AM. A case-control study of an intraoperative corneal abrasion prevention program: Holding the gains made with a continuous quality improvement effort. Jt Comm J Qual Patient Saf 2012; 38:490.</li>
<li>Cucchiara RF, Black S. Corneal abrasion during anesthesia and surgery. Anesthesiology 1988; 69:978.</li>
<li>Wipperman JL1, Dorsch JN. Evaluation and management of corneal abrasions. Am Fam Physician. 2013 Jan 15; 87:114.</li>
<li>Deljou A, Weingarten TN, Mahr MA, et al. Postoperative Corneal Injuries: Incidence and Risk Factors. Anesth Analg 2019; 129:737.</li>
<li>Lentschener C, Ghimouz A, Bonnichon P, et al. Acute postoperative glaucoma after nonocular surgery remains a diagnostic challenge. Anesth Analg 2002; 94:1034.</li>
<li>Fazio DT, Bateman JB, Christensen RE. Acute angle-closure glaucoma associated with surgical anesthesia. Arch Ophthalmol 1985; 103:360.</li>
<li>Eldor J, Admoni M. Acute glaucoma following nonophthalmic surgery. Isr J Med Sci 1989; 25:652.</li>
<li>Gayat E, Gabison E, Devys JM. Case report: Bilateral angle closure glaucoma after general anesthesia. Anesth Analg 2011; 112:126.</li>
<li>DeMere M, Wood T, Austin W. Eye complications with blepharoplasty or other eyelid surgery. A national survey. Plast Reconstr Surg 1974; 53:634.</li>
<li>Stankiewicz JA, Chow JM. Two faces of orbital hematoma in intranasal (endoscopic) sinus surgery. Otolaryngol Head Neck Surg 1999; 120:841.</li>
<li>Gosau M, Schöneich M, Draenert FG, et al. Retrospective analysis of orbital floor fractures--complications, outcome, and review of literature. Clin Oral Investig 2011; 15:305.</li>
<li>Hass AN, Penne RB, Stefanyszyn MA, Flanagan JC. Incidence of postblepharoplasty orbital hemorrhage and associated visual loss. Ophthal Plast Reconstr Surg 2004; 20:426.</li>
<li>Teng CC, Reddy S, Wong JJ, Lisman RD. Retrobulbar hemorrhage nine days after cosmetic blepharoplasty resulting in permanent visual loss. Ophthal Plast Reconstr Surg 2006; 22:388.</li>
<li>Mattke AF, Vender JR, Anstadt MR. Pituitary apoplexy presenting as Addisonian crisis after coronary artery bypass grafting. Tex Heart Inst J 2002; 29:193.</li>
<li>Biousse V, Newman NJ, Oyesiku NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 2001; 71:542.</li>
<li>Randeva HS, Schoebel J, Byrne J, et al. Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol (Oxf) 1999; 51:181.</li>
<li>Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.</li>
<li>Lysandropoulos AP, Rossetti AO. Postictal cortical visual impairment: A symptom of posterior reversible encephalopathy. Epilepsy Behav 2010; 17:276.</li>
<li>Eran A, Barak M. Posterior reversible encephalopathy syndrome after combined general and spinal anesthesia with intrathecal morphine. Anesth Analg 2009; 108:609.</li>
<li>Yi JH, Ha SH, Kim YK, Choi EM. Posterior reversible encephalopathy syndrome in an untreated hypertensive patient after spinal surgery under general anesthesia -A case report-. Korean J Anesthesiol 2011; 60:369.</li>
<li>Kim TK, Yoon JU, Park SC, et al. Postoperative blindness associated with posterior reversible encephalopathy syndrome: A case report. J Anesth 2010; 24:783.</li>
<li>Shen Y, Drum M, Roth S. The prevalence of perioperative visual loss in the United States: A 10-year study from 1996 to 2005 of spinal, orthopedic, cardiac, and general surgery. Anesth Analg 2009; 109:1534.</li>
<li>Roth S. Postoperative blindness. In: Miller's Anesthesia, 6th ed, Miller RD (Ed), Elsevier, New York 2004. p.3001.</li>
<li>Postoperative Visual Loss Study Group. Risk factors associated with ischemic optic neuropathy after spinal fusion surgery. Anesthesiology 2012; 116:15.</li>
<li>Ho VT, Newman NJ, Song S, et al. Ischemic optic neuropathy following spine surgery. J Neurosurg Anesthesiol 2005; 17:38.</li>
<li>Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol 2008; 145:604.</li>
<li>Lee LA, Newman NJ, Wagner TA, et al. Postoperative ischemic optic neuropathy. Spine (Phila Pa 1976) 2010; 35:S105.</li>
<li>Sadda SR, Nee M, Miller NR, et al. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 2001; 132:743.</li>
<li>Hollenhorst RW, Svien HJ, Benoit CF. Unilateral blindness occurring during anesthesia for neurosurgical operations. AMA Arch Ophthalmol 1954; 52:819.</li>
<li>Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 2004; 78:723.</li>
<li>Mizutani AR, Parker J, Katz J, Schmidt J. Visual disturbances, serum glycine levels and transurethral resection of the prostate. J Urol 1990; 144:697.</li>
<li>Radziwill AJ, Vuadens P, Borruat FX, Bogousslavsky J. Visual disturbances and transurethral resection of the prostate: The TURP syndrome. Eur Neurol 1997; 38:7.</li>
<li>Karci A, Erkin Y. Transient blindness following hysteroscopy. J Int Med Res 2003; 31:152.</li>
<li>Wang JM, Creel DJ, Wong KC. Transurethral resection of the prostate, serum glycine levels, and ocular evoked potentials. Anesthesiology 1989; 70:36.</li>
<li>Hahn RG. Dose-dependent half-life of glycine. Urol Res 1993; 21:289.</li>
<li>Hawary A, Mukhtar K, Sinclair A, Pearce I. Transurethral resection of the prostate syndrome: Almost gone but not forgotten. J Endourol 2009; 23:2013.</li>
</ol></div><div id="graphicVersion">Graphic 100340 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
